FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100481432> ?p ?o ?g. }

• W3100481432 endingPage "510.e12" @default.
• W3100481432 startingPage "510.e1" @default.
• W3100481432 abstract "BackgroundIn March 2020, as community spread of severe acute respiratory syndrome coronavirus 2 became increasingly prevalent, pregnant women seemed to be equally susceptible to developing coronavirus disease 2019. Although the disease course usually appears mild, severe and critical cases of coronavirus disease 2019 seem to lead to substantial morbidity, including intensive care unit admission with prolonged hospital stay, intubation, mechanical ventilation, and even death. Although there are recent reports regarding the impact of coronavirus disease 2019 on pregnancy, there is a lack of information regarding the severity of coronavirus disease 2019 in pregnant vs nonpregnant women.ObjectiveWe aimed to describe the outcomes of severe and critical cases of coronavirus disease 2019 in pregnant vs nonpregnant, reproductive-aged women.Study DesignThis is a multicenter, retrospective, case-control study of women with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection hospitalized with severe or critical coronavirus disease 2019 in 4 academic medical centers in New York City and 1 in Philadelphia between March 12, 2020, and May 5, 2020. The cases consisted of pregnant women admitted specifically for severe or critical coronavirus disease 2019 and not for obstetrical indications. The controls consisted of reproductive-aged, nonpregnant women admitted for severe or critical coronavirus disease 2019. The primary outcome was a composite morbidity that includes the following: death, a need for intubation, extracorporeal membrane oxygenation, noninvasive positive pressure ventilation, or a need for high-flow nasal cannula O2 supplementation. The secondary outcomes included intensive care unit admission, length of stay, a need for discharge to long-term acute care facilities, and discharge with a home O2 requirement.ResultsA total of 38 pregnant women with severe acute respiratory syndrome coronavirus 2 polymerase chain reaction-confirmed infections were admitted to 5 institutions specifically for coronavirus disease 2019, 29 (76.3%) meeting the criteria for severe disease status and 9 (23.7%) meeting the criteria for critical disease status. The mean age and body mass index were markedly higher in the nonpregnant control group. The nonpregnant cohort also had an increased frequency of preexisting medical comorbidities, including diabetes, hypertension, and coronary artery disease. The pregnant women were more likely to experience the primary outcome when compared with the nonpregnant control group (34.2% vs 14.9%; P=.03; adjusted odds ratio, 4.6; 95% confidence interval, 1.2–18.2). The pregnant patients experienced higher rates of intensive care unit admission (39.5% vs 17.0%; P<.01; adjusted odds ratio, 5.2; 95% confidence interval, 1.5–17.5). Among the pregnant women who underwent delivery, 72.7% occurred through cesarean delivery and the mean gestational age at delivery was 33.8±5.5 weeks in patients with severe disease status and 35±3.5 weeks in patients with critical coronavirus disease 2019 status.ConclusionPregnant women with severe and critical coronavirus disease 2019 are at an increased risk for certain morbidities when compared with nonpregnant controls. Despite the higher comorbidities of diabetes and hypertension in the nonpregnant controls, the pregnant cases were at an increased risk for composite morbidity, intubation, mechanical ventilation, and intensive care unit admission. These findings suggest that pregnancy may be associated with a worse outcome in women with severe and critical cases of coronavirus disease 2019. Our study suggests that similar to other viral infections such as severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus, pregnant women may be at risk for greater morbidity and disease severity. In March 2020, as community spread of severe acute respiratory syndrome coronavirus 2 became increasingly prevalent, pregnant women seemed to be equally susceptible to developing coronavirus disease 2019. Although the disease course usually appears mild, severe and critical cases of coronavirus disease 2019 seem to lead to substantial morbidity, including intensive care unit admission with prolonged hospital stay, intubation, mechanical ventilation, and even death. Although there are recent reports regarding the impact of coronavirus disease 2019 on pregnancy, there is a lack of information regarding the severity of coronavirus disease 2019 in pregnant vs nonpregnant women. We aimed to describe the outcomes of severe and critical cases of coronavirus disease 2019 in pregnant vs nonpregnant, reproductive-aged women. This is a multicenter, retrospective, case-control study of women with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection hospitalized with severe or critical coronavirus disease 2019 in 4 academic medical centers in New York City and 1 in Philadelphia between March 12, 2020, and May 5, 2020. The cases consisted of pregnant women admitted specifically for severe or critical coronavirus disease 2019 and not for obstetrical indications. The controls consisted of reproductive-aged, nonpregnant women admitted for severe or critical coronavirus disease 2019. The primary outcome was a composite morbidity that includes the following: death, a need for intubation, extracorporeal membrane oxygenation, noninvasive positive pressure ventilation, or a need for high-flow nasal cannula O2 supplementation. The secondary outcomes included intensive care unit admission, length of stay, a need for discharge to long-term acute care facilities, and discharge with a home O2 requirement. A total of 38 pregnant women with severe acute respiratory syndrome coronavirus 2 polymerase chain reaction-confirmed infections were admitted to 5 institutions specifically for coronavirus disease 2019, 29 (76.3%) meeting the criteria for severe disease status and 9 (23.7%) meeting the criteria for critical disease status. The mean age and body mass index were markedly higher in the nonpregnant control group. The nonpregnant cohort also had an increased frequency of preexisting medical comorbidities, including diabetes, hypertension, and coronary artery disease. The pregnant women were more likely to experience the primary outcome when compared with the nonpregnant control group (34.2% vs 14.9%; P=.03; adjusted odds ratio, 4.6; 95% confidence interval, 1.2–18.2). The pregnant patients experienced higher rates of intensive care unit admission (39.5% vs 17.0%; P<.01; adjusted odds ratio, 5.2; 95% confidence interval, 1.5–17.5). Among the pregnant women who underwent delivery, 72.7% occurred through cesarean delivery and the mean gestational age at delivery was 33.8±5.5 weeks in patients with severe disease status and 35±3.5 weeks in patients with critical coronavirus disease 2019 status. Pregnant women with severe and critical coronavirus disease 2019 are at an increased risk for certain morbidities when compared with nonpregnant controls. Despite the higher comorbidities of diabetes and hypertension in the nonpregnant controls, the pregnant cases were at an increased risk for composite morbidity, intubation, mechanical ventilation, and intensive care unit admission. These findings suggest that pregnancy may be associated with a worse outcome in women with severe and critical cases of coronavirus disease 2019. Our study suggests that similar to other viral infections such as severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus, pregnant women may be at risk for greater morbidity and disease severity." @default.
• W3100481432 created "2020-11-23" @default.
• W3100481432 creator A5001480438 @default.
• W3100481432 creator A5014243126 @default.
• W3100481432 creator A5014671931 @default.
• W3100481432 creator A5015144027 @default.
• W3100481432 creator A5020959914 @default.
• W3100481432 creator A5032145412 @default.
• W3100481432 creator A5041477012 @default.
• W3100481432 creator A5042584662 @default.
• W3100481432 creator A5042981297 @default.
• W3100481432 creator A5047601895 @default.
• W3100481432 creator A5057277692 @default.
• W3100481432 creator A5065022635 @default.
• W3100481432 creator A5065033288 @default.
• W3100481432 creator A5073278386 @default.
• W3100481432 creator A5082437748 @default.
• W3100481432 creator A5083936827 @default.
• W3100481432 date "2021-05-01" @default.
• W3100481432 modified "2023-10-11" @default.
• W3100481432 title "Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls" @default.
• W3100481432 cites W2007603900 @default.
• W3100481432 cites W2041013541 @default.
• W3100481432 cites W2043107264 @default.
• W3100481432 cites W2058694455 @default.
• W3100481432 cites W2128916249 @default.
• W3100481432 cites W2474234222 @default.
• W3100481432 cites W2510184442 @default.
• W3100481432 cites W2914868791 @default.
• W3100481432 cites W3001118548 @default.
• W3100481432 cites W3006783394 @default.
• W3100481432 cites W3008028633 @default.
• W3100481432 cites W3008827533 @default.
• W3100481432 cites W3009885589 @default.
• W3100481432 cites W3011534780 @default.
• W3100481432 cites W3012611938 @default.
• W3100481432 cites W3012813435 @default.
• W3100481432 cites W3016123694 @default.
• W3100481432 cites W3016259199 @default.
• W3100481432 cites W3016273932 @default.
• W3100481432 cites W3017673066 @default.
• W3100481432 cites W3019841802 @default.
• W3100481432 cites W3019956037 @default.
• W3100481432 cites W3022711034 @default.
• W3100481432 cites W3023787531 @default.
• W3100481432 cites W3023832502 @default.
• W3100481432 cites W3024320461 @default.
• W3100481432 cites W3028738649 @default.
• W3100481432 cites W3036479639 @default.
• W3100481432 cites W3037168483 @default.
• W3100481432 cites W3081982443 @default.
• W3100481432 cites W4238344918 @default.
• W3100481432 cites W4242966060 @default.
• W3100481432 cites W4379624502 @default.
• W3100481432 doi "https://doi.org/10.1016/j.ajog.2020.11.022" @default.
• W3100481432 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7677036" @default.
• W3100481432 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33221292" @default.
• W3100481432 hasPublicationYear "2021" @default.
• W3100481432 type Work @default.
• W3100481432 sameAs 3100481432 @default.
• W3100481432 citedByCount "118" @default.
• W3100481432 countsByYear W31004814322021 @default.
• W3100481432 countsByYear W31004814322022 @default.
• W3100481432 countsByYear W31004814322023 @default.
• W3100481432 crossrefType "journal-article" @default.
• W3100481432 hasAuthorship W3100481432A5001480438 @default.
• W3100481432 hasAuthorship W3100481432A5014243126 @default.
• W3100481432 hasAuthorship W3100481432A5014671931 @default.
• W3100481432 hasAuthorship W3100481432A5015144027 @default.
• W3100481432 hasAuthorship W3100481432A5020959914 @default.
• W3100481432 hasAuthorship W3100481432A5032145412 @default.
• W3100481432 hasAuthorship W3100481432A5041477012 @default.
• W3100481432 hasAuthorship W3100481432A5042584662 @default.
• W3100481432 hasAuthorship W3100481432A5042981297 @default.
• W3100481432 hasAuthorship W3100481432A5047601895 @default.
• W3100481432 hasAuthorship W3100481432A5057277692 @default.
• W3100481432 hasAuthorship W3100481432A5065022635 @default.
• W3100481432 hasAuthorship W3100481432A5065033288 @default.
• W3100481432 hasAuthorship W3100481432A5073278386 @default.
• W3100481432 hasAuthorship W3100481432A5082437748 @default.
• W3100481432 hasAuthorship W3100481432A5083936827 @default.
• W3100481432 hasBestOaLocation W31004814321 @default.
• W3100481432 hasConcept C116675565 @default.
• W3100481432 hasConcept C126322002 @default.
• W3100481432 hasConcept C131872663 @default.
• W3100481432 hasConcept C159047783 @default.
• W3100481432 hasConcept C2777648638 @default.
• W3100481432 hasConcept C2779134260 @default.
• W3100481432 hasConcept C2779234561 @default.
• W3100481432 hasConcept C3006700255 @default.
• W3100481432 hasConcept C3007834351 @default.
• W3100481432 hasConcept C3008058167 @default.
• W3100481432 hasConcept C524204448 @default.
• W3100481432 hasConcept C54355233 @default.
• W3100481432 hasConcept C71924100 @default.
• W3100481432 hasConcept C86803240 @default.
• W3100481432 hasConceptScore W3100481432C116675565 @default.
• W3100481432 hasConceptScore W3100481432C126322002 @default.

• next